Enhanced/constitutive activation of ERK1/2 occurs in various human cancers, which is related to mutations in genes encoding Ras and B-Raf proteins and/or due to the oxidative stress observed in the tumor microenvironment. Here, MAPK3 is linked to neoplasm.